论文部分内容阅读
目的为我国医药企业专利策略的开展和创新能力的建设提供可行性建议。方法选取一类创新药物恩必普为实证研究对象,从专利创造、管理和实施3个方面,就该企业如何充分利用国家创新政策和专利战略以提高企业创新能力,保证企业可持续发展进行实证检验。结果恩必普的专利策略获得了较好的实施绩效。结论石药集团形成了专利战略运用与企业创新能力提升相互促进共同发展的良性循环,其成功经验,值得我国高新技术企业学习借鉴。
Objective To provide feasible suggestions for the development of patent strategy and innovation capability of medical enterprises in China. Methods Choose a kind of innovative drug Enbip as the empirical research object, from the aspects of patent creation, management and implementation, how to make full use of national innovation policy and patent strategy in order to improve the innovation ability of enterprises and ensure the sustainable development of enterprises test. Results Enbip’s patent strategy achieved good performance. Conclusion Shijiazhuang Pharmaceutical Group has formed a virtuous cycle of promoting the common development of patent strategy application and enterprise innovation capability, and its successful experience deserves our country’s high-tech enterprises to learn from.